Media:   Brandon Cuicchi  646.284.2948




July 25, 2016 – Philadelphia, PA – Over the weekend, the New York and Philadelphia chapters of ACT UP,

the AIDS Coalition To Unleash Power,
teamed up with allies UAEM (Universities Allied for Essential Medicines)
and The Other 98% to stage a tug-of-war with pharma bro’s outside Hillary
Clinton’s Philadelphia campaign headquarters ahead of the Democratic
National Convention.

Activists targeted candidate Clinton for her refusal to renew her 2008
campaign pledges to regulate the price-gouging of medicines made by major
pharmaceutical companies like Gilead and Pfizer.  The high prices make it
hard for people with HIV as well as other people to access the lifesaving
treatment they need.

“Hillary Clinton made pledges to have 30 million on treatment by 2020. 
Many are sick, and some have died waiting for the treatment,” said ACT UP
Philadelphia member Jose De Marco.  “This is not the way to the AIDS Free
Generation she talked about.”

Currently, taxpayers help fund the development of new medicines through
grants from the National Institutes of Health (NIH) to universities.  The
drugs are then licensed to companies to sell back to consumers at high
prices.  “Hillary Clinton must provide concrete solutions for
pharmaceutical price-gouging and challenge the current patent system for
drugs that Americans pay for with their taxes,” said Brandon Cuicchi of

Around thirty people met at the Love Statue in Philadelphia’s City Hall
Park and marched, carrying signs and chanting, to Clinton’s campaign
headquarters a few blocks away.  When they arrived, they were met by a
pharma bro played by comedian John F. O’Donnell from RT’s Redacted Tonight
along with the bigheaded likenesses of other notable pharma bros like
Martin Shkreli.

The pharma bros waved giant moneybags and challenged activists to a
tug-of-war to win influence over Hillary Clinton.

To come from NYC with ACT UP to Philly for the Saturday protest email us at This email address is being protected from spambots. You need JavaScript enabled to view it. or call 917-653-7267

ACT UP and Other Health Activists Rally Against High Drug Prices

NY – Last Thursday, April Fools Day eve, the Washington Post (see reprint) briefly reported that pharmaceutical giant Pfizer, Inc. had “vowed today to stop the time-tested habit of jacking up the list prices of its drugs each year.”

As it turned out, an ad hoc group of activists calling themselves “Nobody’s Fool,” in collaboration with the cyberspace activist group The Yes Men, created the fake press releases and websites. The content of these websites is attached.

The fake website for PhRMA Pharmaceutical Research and Manufacturers of America “announced” a Sustainable Pricing Plan for the 21st Century, an ostensible initiative establishing a new pricing model that would improve access to medications by lowering prices.

On the fake Pfizer website, the company “announced” the immediate end to price increases. Several online media outlets, including the Washington Post, fell for the prank and reported the announcements as real before the websites were shut down. Pfizer has released a statement to disregard the new drug pricing policy and its commitment to “engaging in an honest discussion” with patients about affordable medicines. The community of health activists is open to pursuing this opportunity with Pfizer to discuss improvements in the way medicines are priced so everyone can access the treatment they need.

The next day, April 1, dozens of activists from ACT UP New York and other organizations converged at the New York City headquarters of Pfizer, to demand drug pricing reforms. Activists criticized Pfizer because it:
•    consistently implements price increases that far outstrip the rate of inflation;
•    is engaging in a merger with Irish drug company Allergan to avoid paying


Protesta:  Paren de Matarnos / No en Nuestro Nombre
Dónde: Trump Tower 5ta Ave y calle 56, Manhattan
Nueva York, NY - ACT UP New York junto a líderes de organizaciones musulmanas, Latinxs y LGBTQ protestarán delante de la torre Trump en Nueva York contra el uso por parte del presunto candidato presidencial republicano de la reciente masacre en un bar gay en Orlando para polarizar a los estadounidenses.
El martes 21 de junio de 2016 Donald Trump se reunirá con líderes de múltiples grupos de odio anti-LGBTQ en un intento cínico para explotar la homofobia, la transfobia, la intolerancia contra los musulmanes, y el racismo para superar su históricamente baja aprobación en encuestas y su impopularidad con la mayoría del pueblo de EEUU.
"A poco más de una semana luego de la masacre de decenas de personas LGBTQ en el bar Pulse en Orlando, Donald Trump busca el apoyo y el endoso de grupos que - por décadas - han abogado por el odio, la discriminación y la violencia en contra de nuestra comunidad", dijo James

ACT UP at Pfizer World Headquarters Protesting Drug Prices

On April 1, 2016, we stand in solidarity with a coalition of over 25 health advocacy groups from 6 continents.

In New York, we target Pfizer because it is representative of the deceptive pharmaceutical industry. We are protesting against their

lies and continuous acts of financial greed in their attempts to profit from medicines at the expense patients’ lives and expanding affordable access.

  • Pfizer gouges prices.In January 2016, Pfizer hiked the price of over 100 medicines, by up to 20%, including treatments for breast cancer, mental health, HIV, epilepsy, prostate cancer, pneumonia, skin and gut infections, acute myeloid leukemia, erectile dysfunction, menopause symptoms, diabetic peripheral neuropathy, fibromyalgia, and heart disease. These price increases deviate from costs of inflation and regularly occur over the years.
  • Pfizer lies. They claim that R&D for a medication costs over USD 1 billion dollars. Their propaganda deceives the public to justify that they deserve billions of dollars in profit in order to recoup costs. Pfizer uses millions in public fundsto develop drugs and needs to open its books to reveal the true R&D costs.
  • Pfizer steals. Pfizer merged with Irish company Allergan